title: Class I anti-arrhythmic drugs: structure and function at the cardiac sodium channel.
abstract: The major electrophysiologic effect of Class I anti-arrhythmic drugs is blockade of the cardiac sodium channel thereby reducing the initial depolarization of the action potential and slowing impulse propagation. Despite the widespread use of these drugs, our understanding of their mechanism of action is incomplete. Models based on electrophysiologic studies predict that a receptor for Class I drugs is associated with the sodium channel, and that occupancy of this receptor causes sodium channel blockade. Recent radioligand studies with [3H]batrachotoxin A benzoate have identified a binding site for Class I drugs associated with rat cardiac myocyte sodium channels which may be the predicted receptor. Binding of drugs to this site is saturable, reversible, stereospecific, and occurs at pharmacologically relevant concentrations with similar rank order of potency in vivo and in vitro. Drugs appear to bind preferentially to a closed state of the channel, thereby preventing channel opening and subsequent sodium influx.
authors.affiliation: Cardiovascular Research Group, University of Calgary, Alberta.
authors.forename: R S
authors.initials: RS
authors.lastname: Sheldon
authors.forename: H J
authors.initials: HJ
authors.lastname: Duff
authors.forename: R J
authors.initials: RJ
authors.lastname: Hill
mesh_terms: D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D001496:Batrachotoxins / Q000378:metabolism; D001665:Binding Sites; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D015394:Molecular Structure; D015222:Sodium Channels / Q000187:drug effects* / Q000502:physiology; D013329:Structure-Activity Relationship
chemical_list: D000889:Anti-Arrhythmia Agents; D001496:Batrachotoxins; D015222:Sodium Channels; C031775:batrachotoxinin A 20-alpha-benzoate